Naomi Rosenfeld, LHMC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 543 Mass Ave, Omr, Acton, MA 01720 Phone: 978-264-0160 |
Helen R Frey, MA ED Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 518 Great Rd, Boundaries Therapy Center, Acton, MA 01720 Phone: 978-263-4878 Fax: 978-635-0386 |
Aimee Ryan, M.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 380 Massachusetts Ave, Acton, MA 01720 Phone: 978-263-3006 |
Jason Meyer Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 380 Massachusetts Ave, Acton, MA 01720 Phone: 978-339-3538 |
Cameron Tieuli Counselor Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Avenue, Suite 201, Acton, MA 01720 Phone: 978-273-0201 |
Sarah Kruis Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave, Acton, MA 01720 Phone: 978-263-3427 |
Kayla Trutt Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave Ste 103, Acton, MA 01720 Phone: 978-264-3500 |
Mr. William Gresser, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 162 Great Rd, Acton, MA 01720 Phone: 781-641-4104 |
Ashlyn Kapetanakis Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave Ste 201, Acton, MA 01720 Phone: 978-263-3427 |
Chelsea Balzer Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave, Suite 201, Acton, MA 01720 Phone: 978-263-3427 |
Ladan Miremadi Thompson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 282 Central St, Acton, MA 01720 Phone: 978-472-0224 |
Cody Mitchell Counselor Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave, Acton, MA 01720 Phone: 978-263-3427 |
Zucel Leiva Lopez, BS, M.ED, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 Powdermill Rd Ste 213, Acton, MA 01720 Phone: 978-305-1847 Fax: 978-268-5082 |
Ms. Susanne Avery, LICSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 422 Great Elm Way, Acton, MA 01718 Phone: 978-263-7971 |
Alexa Pappas Counselor Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave, Acton, MA 01720 Phone: 978-263-3427 |
Myroslava Dziuk Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave, Acton, MA 01720 Phone: 978-263-3427 |
Robert Henderson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave, Suite 201, Acton, MA 01720 Phone: 978-263-3427 Fax: 978-263-3498 |
Mrs. Enid J Keefe, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 289 Great Rd Ste G1, Acton, MA 01720 Phone: 978-679-1200 Fax: 978-486-4037 |
Samantha Keen Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave Ste 201, Acton, MA 01720 Phone: 978-263-3498 |
Amy Barr Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Massachusetts Ave Ste 201, Acton, MA 01720 Phone: 978-263-3427 |
News Archive
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
› Verified 9 days ago